| Weekly Plasma EBV DNA for Non-metastatic Nasopharyngeal Carcinoma (NCT03830996) | The University of Hong Kong | 2016-02-01 |
| Concurrent Docetaxel Plus Cisplatin or Cisplatin Alone With IMRT in High Risk Nasopharyngeal Carcinoma (NCT02610556) | Sun Yat-sen University | 2016-01-01 |
| Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy (NCT02582008) | Wake Forest University Health Sciences | 2016-01-01 |
| Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma (NCT02795195) | Shanghai Proton and Heavy Ion Center | 2016-01-01 |
| Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy (NCT04508816) | Fudan University | 2016-01-01 |
| Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma (NCT02621970) | Sun Yat-sen University | 2016-01-01 |
| Treatment of Bevacizumab Followed by Steroid in RN (NCT04553510) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2016-01-01 |
| Individualized Elective Neck Irradiation Based on MRI in NPC Patients (NCT02642107) | Sun Yat-sen University | 2016-01-01 |
| Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma (NCT02610010) | Sun Yat-sen University | 2015-11-01 |
| NBI to Detect Post-RT Mucosal Residual NPC (NCT02584790) | Pamela Youde Nethersole Eastern Hospital | 2015-11-01 |
| Concurrent Chemotherapy for the Intermediate Risk Nasopharyngeal Carcinoma In Intensity-modulated Radiotherapy Era (NCT02633202) | Sun Yat-sen University | 2015-11-01 |
| Trial Evaluating Maintenance Chemotherapy for Metastatic Nasopharyngeal Carcinoma (NCT02944708) | Shanghai Proton and Heavy Ion Center | 2015-10-01 |
| Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma (NCT02801487) | Shanghai Proton and Heavy Ion Center | 2015-09-01 |
| Trail Evaluating Carbon Ion Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma (NCT02569788) | Shanghai Proton and Heavy Ion Center | 2015-09-01 |
| Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal Cancer (NCT03670342) | National Cancer Centre, Singapore | 2015-08-20 |
| PET and MRI in Prognosis Prediction of NPC (NCT03429868) | Chang Gung Memorial Hospital | 2015-08-01 |
| Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma (NCT02293356) | Biotech Pharmaceutical Co., Ltd. | 2015-08-01 |
| A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma (NCT02512315) | Sun Yat-sen University | 2015-08-01 |
| A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC (NCT02590133) | Yun-fei Xia | 2015-07-01 |
| Polymorphisms in Key Genes of Glycolytic Pathway: Influence on Radiosensitivity in Nasopharyngeal Carcinoma (NCT02481089) | Hunan Province Tumor Hospital | 2015-06-01 |
| Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients (NCT02575547) | Zhao Chong | 2015-06-01 |
| Nasopharyngeal Carcinoma Post IMRT (NCT02597426) | University Health Network, Toronto | 2015-06-01 |
| The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT (NCT02460887) | Sun Yat-sen University | 2015-06-01 |
| Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma (NCT02500940) | Taichung Veterans General Hospital | 2015-05-01 |
| HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma (NCT02523430) | Fuda Cancer Hospital, Guangzhou | 2015-05-01 |
| Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma (NCT02460419) | Sun Yat-sen University | 2015-04-01 |
| Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis (NCT02401763) | National Taiwan University Hospital | 2015-04-01 |
| Concurrent Chemotherapy in Intermediate Risk Patients Treated With Intensity-modulated Radiotherapy (NCT02289807) | Sun Yat-sen University | 2015-03-01 |
| Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC (NCT02421640) | Sun Yat-sen University | 2015-03-01 |
| Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma (NCT02434614) | Wei Jiang | 2015-03-01 |
| Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL) (NCT02287311) | Baylor College of Medicine | 2015-02-01 |
| Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NCT03427359) | The University of Hong Kong-Shenzhen Hospital | 2015-01-22 |
| Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma (NCT02633176) | Sun Yat-sen University | 2015-01-01 |
| A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA (NCT02363400) | National Health Research Institutes, Taiwan | 2014-12-14 |
| Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma (NCT02301208) | He Xia | 2014-12-01 |
| A Phase II Study of Icotinib in Treating Patients With Advanced Nasopharyngeal Carcinoma (NCT02328261) | Betta Pharmaceuticals Co., Ltd. | 2014-11-01 |
| Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma (NCT02237924) | First Affiliated Hospital of Guangxi Medical University | 2014-09-01 |
| A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients (NCT02578641) | Tessa Therapeutics | 2014-07-01 |
| Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli (NCT02199132) | Corporacion Parc Tauli | 2014-07-01 |
| Effect of Oral Supplements on the Nutritional Status of Locally Advanced Nasopharyngeal Carcinoma Patients (NCT02776124) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2014-06-01 |
| The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma (NCT02096380) | First People's Hospital of Foshan | 2014-05-01 |
| Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma (NCT02016417) | Cancer Hospital of Guangxi Medical University | 2014-05-01 |
| Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical Study (NCT02187315) | Feng Jing | 2014-05-01 |
| The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma (NCT02537925) | Changjie Huang | 2014-01-01 |
| EUS-FNA for Retropharyngeal Lymph Node (RPLN) in Recurrent Nasopharyngeal Carcinoma (NPC) Patients (NCT03006588) | Sun Yat-sen University | 2014-01-01 |
| OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy (NCT02058017) | National University Hospital, Singapore | 2013-11-01 |
| Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma (NCT01872962) | Sun Yat-sen University | 2013-11-01 |
| Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal Carcinoma (NCT02111460) | Sun Yat-sen University | 2013-10-01 |
| Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients (NCT02044562) | Capital Medical University | 2013-09-01 |
| S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma (NCT03668366) | Fudan University | 2013-08-01 |
| Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis (NCT02063399) | Chinese University of Hong Kong | 2013-07-01 |
| Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC (NCT01854203) | Sun Yat-sen University | 2013-07-01 |
| Study of DC-CIK to Treat NPC (NCT01821495) | Guangxi Medical University | 2013-05-01 |
| The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT (NCT01817023) | Chinese Academy of Medical Sciences | 2013-04-01 |
| NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation (NCT01694576) | Jiangsu Cancer Institute & Hospital | 2012-09-01 |
| Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC (NCT02012062) | Fudan University | 2012-07-01 |
| Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma (NCT01621880) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2012-06-01 |
| The Value of Post-radiation Detectable Plasma EBV DNA in High-risk Nasopharyngeal Carcinoma Patients (NCT03981224) | Taichung Veterans General Hospital | 2012-05-02 |
| Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma (NCT01536223) | Zhejiang Cancer Hospital | 2012-04-01 |
| Nasopharyngeal Carcinoma Screening in Zhongshan City (NCT02501993) | Zhongshan People's Hospital, Guangdong, China | 2012-03-01 |
| 3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal Carcinoma (NCT03810274) | Xinqiao Hospital of Chongqing | 2012-02-01 |
| Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma (NCT01540136) | Sun Yat-sen University | 2012-02-01 |
| Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma (NCT01534585) | Taizhou Hospital | 2012-02-01 |
| Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases (NCT01447056) | Baylor College of Medicine | 2012-02-01 |
| Treatment of Cerebral Radiation Necrosis With GM1, a Prospective Study (NCT01884987) | Fudan University | 2012-01-01 |
| Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma (NCT01417390) | First People's Hospital of Foshan | 2011-11-01 |
| A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma (NCT01479504) | Guangxi Medical University | 2011-11-01 |
| Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC) (NCT01309633) | National University Hospital, Singapore | 2011-09-02 |
| A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors (NCT01462903) | Sun Yat-sen University | 2011-09-01 |
| Prognostic Utility of the Imaging and Biological Signatures in Nasopharyngeal Carcinoma (NCT04417985) | Chang Gung Memorial Hospital | 2011-08-01 |
| Plasma EBV DNA Monitoring in Post-treatment NPC Patients (NCT03973723) | Taichung Veterans General Hospital | 2011-08-01 |
| Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma (NCT01245959) | Sun Yat-sen University | 2011-01-01 |
| Dysphagia Rehabilitation for Nasopharyngeal Carcinoma Patients Post Radiotherapy (NCT01237704) | Chinese University of Hong Kong | 2011-01-01 |
| Hepatic Artery Infusion Pump for NPC Liver Metastases (NCT03876574) | Xiangya Hospital of Central South University | 2011-01-01 |
| Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma (NCT01265147) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2011-01-01 |
| Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma (NCT01271439) | Sun Yat-sen University | 2010-09-01 |
| Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer (NCT01614938) | Fudan University | 2010-08-01 |
| Environmental and Genetic Determinants of Nasopharyngeal Carcinoma (NPC) (NCT01182909) | Far Eastern Memorial Hospital | 2010-08-01 |
| Serial Plasma EBV DNA for Nasopharyngeal Carcinoma (NCT02476669) | The University of Hong Kong | 2010-06-01 |
| Hypoxia Imaging -Guided Radiotherapy of Nasopharyngeal Carcinoma (NCT02089204) | Xuzhou Medical University | 2010-06-01 |
| Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC) (NCT01326559) | Hong Kong Nasopharyngeal Cancer Study Group Limited | 2010-06-01 |
| The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma (NCT01187238) | Chinese Academy of Medical Sciences | 2010-05-01 |
| Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal Carcinoma (NCT01230476) | University of Malaya | 2010-05-01 |
| Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC) (NCT01712919) | Jiangsu Cancer Institute & Hospital | 2010-05-01 |
| Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma (NCT03389295) | Xiayun He, MD | 2010-01-01 |
| Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes (NCT00953420) | Baylor College of Medicine | 2009-11-01 |
| Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma (NCT01449942) | Xiangya Hospital of Central South University | 2009-05-01 |
| A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma (NCT00834093) | Dana-Farber Cancer Institute | 2009-04-01 |
| Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis (NCT01865201) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2009-03-01 |
| Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma (NCT01086488) | Ministry of Health, Malaysia | 2009-01-01 |
| Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC) (NCT00817583) | Fudan University | 2009-01-01 |
| Stereotactic Body Radiotherapy for Head and Neck Tumors (NCT01344356) | Mercy Research | 2008-07-01 |
| Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy (NCT00700440) | Sun Yat-sen University | 2008-07-01 |
| A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma (NCT00705627) | Sun Yat-sen University | 2008-06-01 |
| Trial of E10A in Head and Neck Cancer (NCT00634595) | Sun Yat-sen University | 2008-03-01 |
| Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma (NCT00697905) | Ministry of Health, Malaysia | 2008-01-01 |
| Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma (NCT00778908) | Guangxi Medical University | 2008-01-01 |
| Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA (NCT00535795) | King Faisal Specialist Hospital & Research Center | 2007-09-01 |
| Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL) (NCT00515957) | Baylor College of Medicine | 2007-08-01 |
| LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA) (NCT00516087) | Baylor College of Medicine | 2007-08-01 |